Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2000 Feb;37(2):102–107. doi: 10.1136/jmg.37.2.102

Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by β sarcoglycan mutations

R Barresi 1, B Di 1, T Negri 1, R Brugnoni 1, A Vitali 1, G Felisari 1, A Salandi 1, S Daniel 1, F Cornelio 1, L Morandi 1, M Mora 1
PMCID: PMC1734518  PMID: 10662809

Abstract

Two young males with limb-girdle muscular dystrophy (LGMD) resulting from sarcoglycan deficiency died at 27 (patient 1) and 18 years (patient 2) of severe cardiomyopathy. Genetic analysis showed that they were compound heterozygotes for mutations in the β sarcoglycan gene. One of these mutations, an 8 bp duplication in exon 3, was common to both patients. The second mutation in patient 2 was a 4 bp deletion at the splice donor site of intron 2, not reported previously. Patient 2 had more severe heart and skeletal muscle defects with faster deterioration; no sarcoglycans were detected in his skeletal muscle. The second mutation in patient 1, inferred because the unaffected father carries the 8 bp duplication, was not found. In patient 1, both heart and skeletal muscle were analysed and showed reduction of all sarcoglycans in both tissues and incorrect localisation of α and γ sarcoglycans in heart. Therefore mutations in one sarcoglycan gene can disrupt the entire sarcoglycan complex in both skeletal and cardiac muscle. Differing expression patterns of sarcoglycan components in heart and skeletal muscle could be the result of alternatively spliced transcripts in these tissues. By sequencing an alternative transcript, highly expressed in the heart and skeletal muscle of patient 1, we found an 87 bp cryptic exon not previously reported. Although cardiomyopathy can result from mutations in α and γ sarcoglycans, we show for the first time that the condition can also be caused by mutations in the β sarcoglycan gene. This report therefore expands the phenotype of sarcoglycanopathies and suggests that cardiac function in LGMD patients with defective sarcoglycan expression should be monitored.


Keywords: limb-girdle muscular dystrophy; sarcoglycans; dystrophin associated proteins; cardiomyopathy

Full Text

The Full Text of this article is available as a PDF (246.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barresi R., Confalonieri V., Lanfossi M., Di Blasi C., Torchiana E., Mantegazza R., Jarre L., Nardocci N., Boffi P., Tezzon F. Concomitant deficiency of beta- and gamma-sarcoglycans in 20 alpha-sarcoglycan (adhalin)-deficient patients: immunohistochemical analysis and clinical aspects. Acta Neuropathol. 1997 Jul;94(1):28–35. doi: 10.1007/s004010050668. [DOI] [PubMed] [Google Scholar]
  2. Ben Hamida M., Ben Hamida C., Zouari M., Belal S., Hentati F. Limb-girdle muscular dystrophy 2C: clinical aspects. Neuromuscul Disord. 1996 Dec;6(6):493–494. doi: 10.1016/s0960-8966(96)00395-1. [DOI] [PubMed] [Google Scholar]
  3. Bushby K. M., Beckmann J. S. The limb-girdle muscular dystrophies--proposal for a new nomenclature. Neuromuscul Disord. 1995 Jul;5(4):337–343. doi: 10.1016/0960-8966(95)00005-8. [DOI] [PubMed] [Google Scholar]
  4. Bönnemann C. G., Modi R., Noguchi S., Mizuno Y., Yoshida M., Gussoni E., McNally E. M., Duggan D. J., Angelini C., Hoffman E. P. Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet. 1995 Nov;11(3):266–273. doi: 10.1038/ng1195-266. [DOI] [PubMed] [Google Scholar]
  5. Bönnemann C. G., Passos-Bueno M. R., McNally E. M., Vainzof M., de Sá Moreira E., Marie S. K., Pavanello R. C., Noguchi S., Ozawa E., Zatz M. Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). Hum Mol Genet. 1996 Dec;5(12):1953–1961. doi: 10.1093/hmg/5.12.1953. [DOI] [PubMed] [Google Scholar]
  6. Bönnemann C. G., Wong J., Ben Hamida C., Hamida M. B., Hentati F., Kunkel L. M. LGMD 2E in Tunisia is caused by a homozygous missense mutation in beta-sarcoglycan exon 3. Neuromuscul Disord. 1998 May;8(3-4):193–197. doi: 10.1016/s0960-8966(98)00014-5. [DOI] [PubMed] [Google Scholar]
  7. Campbell K. P., Kahl S. D. Association of dystrophin and an integral membrane glycoprotein. Nature. 1989 Mar 16;338(6212):259–262. doi: 10.1038/338259a0. [DOI] [PubMed] [Google Scholar]
  8. Duggan D. J., Gorospe J. R., Fanin M., Hoffman E. P., Angelini C. Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med. 1997 Feb 27;336(9):618–624. doi: 10.1056/NEJM199702273360904. [DOI] [PubMed] [Google Scholar]
  9. Eymard B., Romero N. B., Leturcq F., Piccolo F., Carrié A., Jeanpierre M., Collin H., Deburgrave N., Azibi K., Chaouch M. Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology. 1997 May;48(5):1227–1234. doi: 10.1212/wnl.48.5.1227. [DOI] [PubMed] [Google Scholar]
  10. Fadic R., Sunada Y., Waclawik A. J., Buck S., Lewandoski P. J., Campbell K. P., Lotz B. P. Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy. N Engl J Med. 1996 Feb 8;334(6):362–366. doi: 10.1056/NEJM199602083340604. [DOI] [PubMed] [Google Scholar]
  11. Lim L. E., Campbell K. P. The sarcoglycan complex in limb-girdle muscular dystrophy. Curr Opin Neurol. 1998 Oct;11(5):443–452. doi: 10.1097/00019052-199810000-00006. [DOI] [PubMed] [Google Scholar]
  12. Lim L. E., Duclos F., Broux O., Bourg N., Sunada Y., Allamand V., Meyer J., Richard I., Moomaw C., Slaughter C. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet. 1995 Nov;11(3):257–265. doi: 10.1038/ng1195-257. [DOI] [PubMed] [Google Scholar]
  13. Morandi L., Mora M., Confalonieri V., Barresi R., Di Blasi C., Brugnoni R., Bernasconi P., Mantegazza R., Dworzak F., Antozzi C. Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype. J Neurol Sci. 1995 Oct;132(2):146–155. doi: 10.1016/0022-510x(95)00147-t. [DOI] [PubMed] [Google Scholar]
  14. Muntoni F., Wilson L., Marrosu G., Marrosu M. G., Cianchetti C., Mestroni L., Ganau A., Dubowitz V., Sewry C. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Invest. 1995 Aug;96(2):693–699. doi: 10.1172/JCI118112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nigro V., Okazaki Y., Belsito A., Piluso G., Matsuda Y., Politano L., Nigro G., Ventura C., Abbondanza C., Molinari A. M. Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Genet. 1997 Apr;6(4):601–607. doi: 10.1093/hmg/6.4.601. [DOI] [PubMed] [Google Scholar]
  16. Nigro V., Piluso G., Belsito A., Politano L., Puca A. A., Papparella S., Rossi E., Viglietto G., Esposito M. G., Abbondanza C. Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum Mol Genet. 1996 Aug;5(8):1179–1186. doi: 10.1093/hmg/5.8.1179. [DOI] [PubMed] [Google Scholar]
  17. Nigro V., de Sá Moreira E., Piluso G., Vainzof M., Belsito A., Politano L., Puca A. A., Passos-Bueno M. R., Zatz M. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet. 1996 Oct;14(2):195–198. doi: 10.1038/ng1096-195. [DOI] [PubMed] [Google Scholar]
  18. Noguchi S., McNally E. M., Ben Othmane K., Hagiwara Y., Mizuno Y., Yoshida M., Yamamoto H., Bönnemann C. G., Gussoni E., Denton P. H. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science. 1995 Nov 3;270(5237):819–822. doi: 10.1126/science.270.5237.819. [DOI] [PubMed] [Google Scholar]
  19. Olson T. M., Michels V. V., Thibodeau S. N., Tai Y. S., Keating M. T. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science. 1998 May 1;280(5364):750–752. doi: 10.1126/science.280.5364.750. [DOI] [PubMed] [Google Scholar]
  20. Piccolo F., Roberds S. L., Jeanpierre M., Leturcq F., Azibi K., Beldjord C., Carrié A., Récan D., Chaouch M., Reghis A. Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat Genet. 1995 Jun;10(2):243–245. doi: 10.1038/ng0695-243. [DOI] [PubMed] [Google Scholar]
  21. Roberds S. L., Leturcq F., Allamand V., Piccolo F., Jeanpierre M., Anderson R. D., Lim L. E., Lee J. C., Tomé F. M., Romero N. B. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell. 1994 Aug 26;78(4):625–633. doi: 10.1016/0092-8674(94)90527-4. [DOI] [PubMed] [Google Scholar]
  22. Towbin J. A. The role of cytoskeletal proteins in cardiomyopathies. Curr Opin Cell Biol. 1998 Feb;10(1):131–139. doi: 10.1016/s0955-0674(98)80096-3. [DOI] [PubMed] [Google Scholar]
  23. Yoshida M., Ozawa E. Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem. 1990 Nov;108(5):748–752. doi: 10.1093/oxfordjournals.jbchem.a123276. [DOI] [PubMed] [Google Scholar]
  24. Yoshida M., Suzuki A., Yamamoto H., Noguchi S., Mizuno Y., Ozawa E. Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside. Eur J Biochem. 1994 Jun 15;222(3):1055–1061. doi: 10.1111/j.1432-1033.1994.tb18958.x. [DOI] [PubMed] [Google Scholar]
  25. van der Kooi A. J., de Voogt W. G., Barth P. G., Busch H. F., Jennekens F. G., Jongen P. J., de Visser M. The heart in limb girdle muscular dystrophy. Heart. 1998 Jan;79(1):73–77. doi: 10.1136/hrt.79.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES